This is a live stream. To attend this event in person for free, please click here.
Join leading experts to hear about the state of diabetes care in 2022, and the latest developments in the research and treatment of complications.
Diabetes currently affects 4.9m people in the UK, and with diagnoses doubling in the last 15 years, estimates suggest that one in ten people in this country could have diabetes by 2030.
This conference held by the Royal Society of Medicine will offer insight into how the pandemic has changed Type-2 diabetes care, the causal links between Covid and diabetes, the latest data on prevention and remission, and what the future holds for the treatment of complications in secondary care.
During this event you will:
- Understand how Covid has changed the landscape of how Type-2 diabetes care is delivered
- Learn the latest information about the causal links between Covid and diabetes
- Explore the latest data on prevention and remission in the UK
- Gain updates on what’s new in in-patient care of diabetes
- Understand the latest developments in the research and treatment of a range of complications
The conference will feature presentations and panel discussions featuring expert speakers including Professor Edward Gregg, Dr Shivani Misra, Dr Chirag Bakhai, Professor Sobha Sivaprasad, Professor Jeremy Tomlinson, and Professor Andrew Boulton.
We would like to thank our sponsor Novo Nordisk for their support for this meeting. Novo Nordisk has provided sponsorship to the Royal Society of Medicine to support the costs of running this meeting. Novo Nordisk has had no influence over the meeting arrangements, agenda or selection of speakers apart from the Novo Nordisk symposium.
Follow us on:
Facebook
Instagram
LinkedIn
Twitter
YouTube